ProCE Banner Activity


Cultivating Inclusivity: Paving the Path to Improved Diversity in Clinical Trials


Watch as an expert faculty member discusses the impact of inclusivity in clinical research and explores strategies to overcome barriers to diversifying patient populations in clinical trials.

Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: June 17, 2024

Expiration: June 16, 2025



Rahn Kennedy Bailey

Rahn Kennedy Bailey, MD, DFAPA, ACP

Kathleen & John Bricker Chair
Professor & Head
Department of Psychiatry
Assistant Dean, Diversity & Community Engagement
Chairman, Board of Trustees
Cobb Research Institute
New Orleans, Louisiana

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc.

Target Audience

This program is intended for HCPs that care for psychiatric patients and/or contribute to research efforts in clinical psychopharmacology, including psychiatrists, nurse practitioners, physician associates, pharmacists, and nurses. To improve diversity in clinical trials, a multi-stakeholder approach is necessary to educate all HCPs that are involved in the process. 

Program Learning Goal

The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Psychiatry.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Identify implications for lacking diversity in the patient populations of clinical trials

  • Formulate strategies to address barriers to diversifying patient populations in clinical trials

  • Outline the steps needed to enroll patients into clinical trials


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Rahn Kennedy Bailey, MD, DFAPA, ACP

Kathleen & John Bricker Chair
Professor & Head
Department of Psychiatry
Assistant Dean, Diversity & Community Engagement
Chairman, Board of Trustees
Cobb Research Institute
New Orleans, Louisiana

Rahn Kennedy Bailey, MD, DFAPA, ACP, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Michael Asbach, DMSc, PA-C, as noted below.​

Michael Asbach, DMSc, PA-Cconsultant/advisor/speaker: AbbVie, Avanir, Intra-Cellular, Janssen, Neurocrine, Otsuka, Sage/Biogen.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 17, 2024, through June 16, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-24-144-H01-P 

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

ABMS Approval Statement

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory Cultivating Inclusivity: Paving the Path to Improved Diversity in Clinical Trials has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: ​

ABMS Lifelong Learning CME Activity​

Psychiatry and Neurology

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit to create your account.